Role of the Adipocyte in Development of Type 2 Diabetes / / edited by Coleen Croniger.
Adipocytes are important in the body for maintaining proper energy balance by storing excess energy as triglycerides. However, efforts of the last decade have identified several molecules that are secreted from adipocytes, such as leptin, which are involved in signaling between tissues and organs. T...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | [Place of publication not identified] : : IntechOpen,, 2011. |
Year of Publication: | 2011 |
Language: | English |
Physical Description: | 1 online resource (384 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993547884304498 |
---|---|
ctrlnum |
(CKB)3230000000076895 (NjHacI)993230000000076895 (oapen)https://directory.doabooks.org/handle/20.500.12854/65155 (EXLCZ)993230000000076895 |
collection |
bib_alma |
record_format |
marc |
spelling |
Croniger, Coleen edt Role of the Adipocyte in Development of Type 2 Diabetes / edited by Coleen Croniger. IntechOpen 2011 [Place of publication not identified] : IntechOpen, 2011. 1 online resource (384 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on: online resource; title from PDF information screen (InTech, viewed October 15, 2022). Includes bibliographical references and index. Adipocytes are important in the body for maintaining proper energy balance by storing excess energy as triglycerides. However, efforts of the last decade have identified several molecules that are secreted from adipocytes, such as leptin, which are involved in signaling between tissues and organs. These adipokines are important in overall regulation of energy metabolism and can regulate body composition as well as glucose homeostasis. Excess lipid storage in tissues other than adipose can result in development of diabetes and nonalcoholic fatty liver disease (NAFLD). In this book we review the role of adipocytes in development of insulin resistance, type 2 diabetes and NAFLD. Because type 2 diabetes has been suggested to be a disease of inflammation we included several chapters on the mechanism of inflammation modulating organ injury. Finally, we conclude with a review on exercise and nutrient regulation for the treatment of type 2 diabetes and its co-morbidities. English Endocrinology. Endocrinology 953-307-598-8 Croniger, Coleen, editor. |
language |
English |
format |
eBook |
author2 |
Croniger, Coleen, |
author_facet |
Croniger, Coleen, |
author2_variant |
c c cc c c cc |
author2_role |
TeilnehmendeR |
title |
Role of the Adipocyte in Development of Type 2 Diabetes / |
spellingShingle |
Role of the Adipocyte in Development of Type 2 Diabetes / |
title_full |
Role of the Adipocyte in Development of Type 2 Diabetes / edited by Coleen Croniger. |
title_fullStr |
Role of the Adipocyte in Development of Type 2 Diabetes / edited by Coleen Croniger. |
title_full_unstemmed |
Role of the Adipocyte in Development of Type 2 Diabetes / edited by Coleen Croniger. |
title_auth |
Role of the Adipocyte in Development of Type 2 Diabetes / |
title_new |
Role of the Adipocyte in Development of Type 2 Diabetes / |
title_sort |
role of the adipocyte in development of type 2 diabetes / |
publisher |
IntechOpen IntechOpen, |
publishDate |
2011 |
physical |
1 online resource (384 pages) |
isbn |
953-51-6495-3 953-307-598-8 |
callnumber-first |
Q - Science |
callnumber-subject |
QP - Physiology |
callnumber-label |
QP187 |
callnumber-sort |
QP 3187 R654 42011 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.4 |
dewey-sort |
3616.4 |
dewey-raw |
616.4 |
dewey-search |
616.4 |
work_keys_str_mv |
AT cronigercoleen roleoftheadipocyteindevelopmentoftype2diabetes |
status_str |
n |
ids_txt_mv |
(CKB)3230000000076895 (NjHacI)993230000000076895 (oapen)https://directory.doabooks.org/handle/20.500.12854/65155 (EXLCZ)993230000000076895 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Role of the Adipocyte in Development of Type 2 Diabetes / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1787548444486795264 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01024nam a2200289 i 4500</leader><controlfield tag="001">993547884304498</controlfield><controlfield tag="005">20221012211149.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221012s2011 xx ob 001 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-6495-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)3230000000076895</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)993230000000076895</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/65155</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)993230000000076895</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QP187</subfield><subfield code="b">.R654 2011</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.4</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Croniger, Coleen</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Role of the Adipocyte in Development of Type 2 Diabetes /</subfield><subfield code="c">edited by Coleen Croniger.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2011</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[Place of publication not identified] :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2011.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (384 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (InTech, viewed October 15, 2022).</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Adipocytes are important in the body for maintaining proper energy balance by storing excess energy as triglycerides. However, efforts of the last decade have identified several molecules that are secreted from adipocytes, such as leptin, which are involved in signaling between tissues and organs. These adipokines are important in overall regulation of energy metabolism and can regulate body composition as well as glucose homeostasis. Excess lipid storage in tissues other than adipose can result in development of diabetes and nonalcoholic fatty liver disease (NAFLD). In this book we review the role of adipocytes in development of insulin resistance, type 2 diabetes and NAFLD. Because type 2 diabetes has been suggested to be a disease of inflammation we included several chapters on the mechanism of inflammation modulating organ injury. Finally, we conclude with a review on exercise and nutrient regulation for the treatment of type 2 diabetes and its co-morbidities.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Endocrinology.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Endocrinology</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">953-307-598-8</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Croniger, Coleen,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-02-22 20:20:14 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2012-12-09 08:17:33 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338637880004498&Force_direct=true</subfield><subfield code="Z">5338637880004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338637880004498</subfield></datafield></record></collection> |